Robert Alter
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Polyomavirus and related diseases
-
- Renal cell carcinoma treatment
Papers in ⓘ
-
- Renal cell carcinoma treatment 18
- Prostate Cancer Treatment and Research 4
-
- Cancer Genomics and Diagnostics 6
- Co-authors
- Robert A. Preti (1 shared paper)Stanley E. Waintraub (1 shared paper)Stuart L. Goldberg (1 shared paper)Scott D. Rowley (1 shared paper)Andrew L. Pecora (1 shared paper)Michael B. Atkins (16 shared papers)David F. McDermott (10 shared papers)Elizabeth R. Plimack (13 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Journal for ImmunoTherapy of Cancer (3 papers)Annals of Oncology (3 papers)Cancer (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Robert Alter
29 papers receiving 462 citations
Peers
Comparison fields: 5 of 44
- Oncology 264
- Pulmonary and Respiratory Medicine 206
- Cancer Research 88
- Immunology 91
- Genetics 40
Countries citing papers authored by Robert Alter
This map shows the geographic impact of Robert Alter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Alter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Alter more than expected).
Fields of papers citing papers by Robert Alter
This network shows the impact of papers produced by Robert Alter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Alter. The network helps show where Robert Alter may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Alter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 133 | |
| 2 | 2022 | 85 | |
| 3 | 2020 | 42 | |
| 4 | 2021 | 34 | |
| 5 | 1994 | 30 | |
| 6 | 2016 | 21 | |
| 7 | 2019 | 21 | |
| 8 | 2023 | 19 | |
| 9 | 2019 | 17 | |
| 10 | 2021 | 13 | |
| 11 | 2022 | 6 | |
| 12 | 2018 | 5 | |
| 13 | 2018 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2014 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2015 | 3 | |
| 20 | 2015 | 2 |
About Robert Alter
Robert Alter is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Modeling and Simulation and Immunology, having authored 29 papers that have together received 466 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (18 papers), Cancer Immunotherapy and Biomarkers (12 papers), Renal and related cancers (8 papers), Cancer Genomics and Diagnostics (6 papers), Prostate Cancer Treatment and Research (4 papers), Immunotherapy and Immune Responses (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and TGF-β signaling in diseases (2 papers). The work is most often cited by research in Oncology (264 citations), Pulmonary and Respiratory Medicine (206 citations), Cancer Research (88 citations), Immunology (91 citations) and Genetics (40 citations). Robert Alter has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Robert A. Preti, Stanley E. Waintraub, Stuart L. Goldberg, Scott D. Rowley, Andrew L. Pecora, Michael B. Atkins, David F. McDermott, Elizabeth R. Plimack, Ivor Percent and Joshua Zhang. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Annals of Oncology, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.